This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Jan 19;283(3):338-9.

doi: 10.1001/jama.283.3.338.

Estrogen-receptor status in breast cancer

Y H Kuo

PMID: 10647792
DOI: 10.1001/jama.283.3.338

Comment

Estrogen-receptor status in breast cancer

Y H Kuo. JAMA. 2000.

. 2000 Jan 19;283(3):338-9.

doi: 10.1001/jama.283.3.338.

Author

Y H Kuo

PMID: 10647792
DOI: 10.1001/jama.283.3.338

No abstract available

PubMed Disclaimer

Comment on

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC. Cummings SR, et al. JAMA. 1999 Jun 16;281(23):2189-97. doi: 10.1001/jama.281.23.2189. JAMA. 1999. PMID: 10376571 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information